Invitel Holdings A/S is a leading alternative telecommunications provider in Hungary, recognized as the second-largest fixed-line telecommunications and broadband internet services provider in the country. The company offers a comprehensive range of services, including voice, data, and internet solutions for both residential and business customers. In addition to standard telephony, Invitel provides multimedia and entertainment options such as interactive, digital, and high-definition television, along with fast internet services. By focusing on quality and reliability, Invitel aims to ensure uninterrupted telecommunications and entertainment experiences for its clients across its regional networks.
Private Equity Round in 2015
Walltopia OOD, founded in 1996 and headquartered in Sofia, Bulgaria, specializes in designing and manufacturing artificial climbing structures for a variety of sectors, including private, public, and non-profit. The company is recognized as a global leader in climbing wall production, having completed over 1,300 projects in 50 countries. Walltopia's offerings include mobile solutions, harmonized walls, DIY options, and fun walls specifically designed for climbing gyms, educational institutions, shopping centers, hotels, and recreational facilities. Additionally, the company provides essential accessories such as flooring, safety devices, holds, and volumes. Walltopia has expanded its portfolio to include products and services for the amusement and entertainment industry, with innovative concepts like Funtopia and Rollglider being installed worldwide. Their services encompass architecture and design, engineering, project management, assembly, maintenance, and business consulting. With offices in the United States, the United Kingdom, Canada, Germany, Russia, and the Asia Pacific, Walltopia exports its products globally, enhancing the indoor climbing experience through safety and enjoyment.
Private Equity Round in 2015
Bioton S.A. is a biotechnological company based in Ozarów Mazowiecki, Poland, specializing in the development, manufacturing, and marketing of pharmaceuticals. The company's primary focus is on diabetes treatment, offering products such as recombinant human insulin and oral hypoglycemic agents like glimepiride and metformin. In addition to these core products, Bioton also provides a range of dietary supplements and over-the-counter (OTC) items designed for patients with metabolic syndrome and diabetes-related health issues. This includes supplements for cardiovascular health and skin treatment products. The company operates both domestically and internationally, with a significant portion of its revenue generated from the Polish market.